Evidence map›Paper›PMID 18234841›Full record

ArticleMolecular biology of the cell2008

Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Travis J Wiles, Bijaya K Dhakal, Danelle S Eto, Matthew A Mulvey

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 109 citations in OpenAlex.

  1. Phosphorylation of the βScientific reports · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. UropathogenicMicroorganisms · 2023
    Review
  9. Toxins · 2023
    Article
  10. Article
  11. Article
  12. Virulence · 2022
    Article
  13. Article
  14. Microorganisms · 2022
    Review
  15. Article
  16. Article
  17. Toxins · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Travis J WilesDivision of Cell Biology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112-0565, USA.
Bijaya K Dhakal
Danelle S Eto
Matthew A Mulvey
University of Utah · US

Funding

Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
Bacterial Invasion and Trafficking within the BladderR01DK068585 · NIDDK · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2004 to 2010
$2.4M
Control of bladder infections by NF-kappaBR21DK069526 · NIDDK · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2004 to 2005
$336k
NIAID NIH HHS T32 AI055434NIDDK NIH HHS DK-068585NIDDK NIH HHS DK-069526NIDDK NIH HHS R01 DK068585NIDDK NIH HHS R21 DK069526
6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) are the major cause of urinary tract infections (UTIs), and they have the capacity to induce the death and exfoliation of target uroepithelial cells. This process can be facilitated by the pore-forming toxin alpha-hemolysin (HlyA), which is expressed and secreted by many UPEC isolates. Here, we demonstrate that HlyA can potently inhibit activation of Akt (protein kinase B), a key regulator of host cell survival, inflammatory responses, proliferation, and metabolism. HlyA ablates Akt activation via an extracellular calcium-dependent, potassium-independent process requiring HlyA insertion into the host plasma membrane and subsequent pore formation. Inhibitor studies indicate that Akt inactivation by HlyA involves aberrant stimulation of host protein phosphatases. We found that two other bacterial pore-forming toxins (aerolysin from Aeromonas species and alpha-toxin from Staphylococcus aureus) can also markedly attenuate Akt activation in a dose-dependent manner. These data suggest a novel mechanism by which sublytic concentrations of HlyA and other pore-forming toxins can modulate host cell survival and inflammatory pathways during the course of a bacterial infection.

Indexed as

Bacterial ToxinsBase SequenceCell LineDNA, BacterialEpithelial CellsEscherichia coliEscherichia coli ProteinsHemolysin ProteinsHumansPore Forming Cytotoxic ProteinsProto-Oncogene Proteins c-aktRecombinant ProteinsRNA, Small InterferingSignal TransductionUrinary BladderUrinary Tract InfectionsBacterial ToxinsDNA, BacterialEscherichia coli ProteinsHemolysin ProteinsHlya protein, E coliPore Forming Cytotoxic ProteinsProto-Oncogene Proteins c-aktRecombinant ProteinsRNA, Small Interfering

Identifiers

PMID18234841
PMCPMC2291440
OpenAlexW2145939196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.